FDA Inspection 947620 — Acella Pharmaceuticals, LLC

Acella Pharmaceuticals, LLC — FEI 3006691461

The FDA completed an inspection of Acella Pharmaceuticals, LLC on October 28, 2015 in Alpharetta, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 28, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Alpharetta, GA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
1564221 CFR 111.455(a)Hold - temperature, humidity, light
434221 CFR 211.142(b)Storage under appropriate conditions